Modern computed tomographic pulmonary angiography (CTPA) has excellent resolution and frequently detects distal, subsegmental pulmonary embolisms (SSPEs). These can be challenging to differentiate from artifact, and interobserver reliability is poor.1 Furthermore, the clinical significance of an isolated SSPE is questionable.2,3 For such cases, we determined how often clinicians opted for clinical surveillance over therapeutic anticoagulation in our center.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
All patients who receive anticoagulation therapy are at risk for adverse events. Pulmonary embolism is a "non second chance condition" for the patient. The co-morbidity that put the patient at risk of developing pulmonary embolism must also be considered.
Some patients with pulmonary embolism who have late complications from anticoagulation therapy might have been dead if they had not had the opportunity to survive through this treatment. Caution in using anticoagulation therapy in some patients with pulmonary embolism must be balanced against providing the patient with the best chance to continue to fight to survive.
Raslan IA, Chong J, Gallix B, Lee TC, McDonald EG. Rates of Overtreatment and Treatment-Related Adverse Effects Among Patients With Subsegmental Pulmonary Embolism. JAMA Intern Med. Published online July 30, 2018. doi:10.1001/jamainternmed.2018.2971
Customize your JAMA Network experience by selecting one or more topics from the list below.